Roberto Burioni

Title: The Innovative Contributions of Roberto Burioni

Introduction

Roberto Burioni is a prominent inventor based in Del Mar, California. He has made significant contributions to the field of antibody research, holding a total of 3 patents. His work focuses on novel methods for the identification and isolation of antibodies that bind to unique epitopes.

Latest Patents

Burioni's latest patents include innovative methods for antibody capture assays. One of his notable inventions is an antibody for ligand capture assay, which provides a novel method for identifying and clonal isolation of antibodies. This method utilizes antibodies as solid phase capture reagents to bind a known capture antibody epitope, preventing it from being presented to a population of antibodies for screening. This approach is particularly effective for screening libraries of cloned antibodies, such as phage display combinatorial antibodies. An antibody specific for herpes simplex virus (HSV) was employed as a model for this assay. Another patent, titled ligand capture-directed selection of antibody, shares similar methodologies and applications, further emphasizing Burioni's expertise in this area.

Career Highlights

Roberto Burioni is affiliated with The Scripps Research Institute, where he continues to advance his research in antibody technology. His work has garnered attention for its potential applications in therapeutic and diagnostic settings.

Collaborations

Burioni has collaborated with notable scientists in his field, including Dennis R. Burton and Pietro Paolo Sanna. These collaborations have contributed to the advancement of his research and the development of innovative solutions in antibody technology.

Conclusion

Roberto Burioni's contributions to the field of antibody research are significant and impactful. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge and technology.